skip to main content
10.1145/3447548.3470796acmconferencesArticle/Chapter ViewAbstractPublication PageskddConference Proceedingsconference-collections
abstract

Artificial Intelligence for Drug Discovery

Published: 14 August 2021 Publication History

Abstract

Drug discovery is a long and costly process, taking on average 10 years and 2.5 billion dollars to develop a new drug. Artificial intelligence has the potential to significantly accelerate the process of drug discovery by analyzing a large amount of data generated in the biomedical domain such as bioassays, chemical experiments, and biomedical literature. Recently, there is a growing interesting in developing AI techniques for drug discovery in many different communities including machine learning, data mining, and biomedical community. In this tutorial, we will provide a detailed introduction to key problems in drug discovery such as molecular property prediction, de novo molecular design and molecular optimization, retrosynthesis reaction and prediction, and drug repurposing and combination, and also key technique advancements with artificial intelligence for these problems. This tutorial can be served as introduction materials for both computer scientist interested in drug discovery as well as drug discovery practitioners for learning the latest AI techniques along this direction.

References

[1]
Feixiong Cheng, Rishi J Desai, Diane E Handy, Ruisheng Wang, Sebastian Schneeweiss, Alberto-László Barabási, and Joseph Loscalzo. 2018. Networkbased approach to prediction and population-based validation of in silico drug repurposing. Nature communications 9, 1 (2018), 1--12.
[2]
Hanjun Dai, Chengtao Li, Connor Coley, Bo Dai, and Le Song. 2019. Retrosynthesis prediction with conditional graph logic network. In Advances in Neural Information Processing Systems. 8872--8882.
[3]
Justin Gilmer, Samuel S Schoenholz, Patrick F Riley, Oriol Vinyals, and George E Dahl. 2017. Neural message passing for quantum chemistry. arXiv preprint arXiv:1704.01212 (2017).
[4]
Deisy Morselli Gysi, Ítalo Do Valle, Marinka Zitnik, Asher Ameli, Xiao Gan, Onur Varol, Helia Sanchez, Rebecca Marlene Baron, Dina Ghiassian, Joseph Loscalzo, et al. 2020. Network medicine framework for identifying drug repurposing opportunities for covid-19. arXiv preprint arXiv:2004.07229 (2020).
[5]
Weihua Hu, Bowen Liu, Joseph Gomes, Marinka Zitnik, Percy Liang, Vijay Pande, and Jure Leskovec. 2019. Strategies for Pre-training Graph Neural Networks. arXiv preprint arXiv:1905.12265 (2019).
[6]
Wengong Jin, Regina Barzilay, and Tommi Jaakkola. 2018. Junction tree variational autoencoder for molecular graph generation. ICML (2018).
[7]
Wengong Jin, Connor Coley, Regina Barzilay, and Tommi Jaakkola. 2017. Predicting organic reaction outcomes with weisfeiler-lehman network. In Advances in Neural Information Processing Systems. 2607--2616.
[8]
Thomas N Kipf and Max Welling. 2016. Semi-supervised classification with graph convolutional networks. arXiv preprint arXiv:1609.02907 (2016).
[9]
Miko?aj Sacha, Miko?aj B?a?, Piotr Byrski, Pawe? W?odarczyk-Pruszy'ski, and Stanis?aw Jastrz?bski. 2020. Molecule Edit Graph Attention Network: Modeling Chemical Reactions as Sequences of Graph Edits. arXiv preprint arXiv:2006.15426 (2020).
[10]
Philippe Schwaller, Teodoro Laino, Théophile Gaudin, Peter Bolgar, Christopher A Hunter, Costas Bekas, and Alpha A Lee. 2019. Molecular transformer: A model for uncertainty-calibrated chemical reaction prediction. ACS central science 5, 9 (2019), 1572--1583.
[11]
Chence Shi, Minkai Xu, Hongyu Guo, Ming Zhang, and Jian Tang. 2020. A Graph to Graphs Framework for Retrosynthesis Prediction. ICML (2020).
[12]
Chence Shi, Minkai Xu, Zhaocheng Zhu, Weinan Zhang, Ming Zhang, and Jian Tang. 2020. GraphAF: a flow-based autoregressive model for molecular graph generation. ICLR (2020).
[13]
Fan-Yun Sun, Jordan Hoffmann, Vikas Verma, and Jian Tang. 2020. Infograph: Unsupervised and semi-supervised graph-level representation learning via mutual information maximization. ICLR (2020).
[14]
Keyulu Xu, Weihua Hu, Jure Leskovec, and Stefanie Jegelka. 2018. How powerful are graph neural networks? arXiv preprint arXiv:1810.00826 (2018).
[15]
Jiaxuan You, Bowen Liu, Zhitao Ying, Vijay Pande, and Jure Leskovec. 2018. Graph convolutional policy network for goal-directed molecular graph generation. In Advances in neural information processing systems. 6410--6421.
[16]
Chengxi Zang and Fei Wang. 2020. MoFlow: An Invertible Flow Model for Generating Molecular Graphs. In Proceedings of the 26th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining. 617--626.
[17]
Yadi Zhou, Yuan Hou, Jiayu Shen, Asha Kallianpur, Joe Zein, Daniel A Culver, Samar Farha, Suzy Comhair, Claudio Fiocchi, Michaela U Gack, et al. 2020. A Network Medicine Approach to Investigation and Population-based Validation of Disease Manifestations and Drug Repurposing for COVID-19. ChemRxiv (2020).

Cited By

View all

Index Terms

  1. Artificial Intelligence for Drug Discovery

    Recommendations

    Comments

    Information & Contributors

    Information

    Published In

    cover image ACM Conferences
    KDD '21: Proceedings of the 27th ACM SIGKDD Conference on Knowledge Discovery & Data Mining
    August 2021
    4259 pages
    ISBN:9781450383325
    DOI:10.1145/3447548
    Permission to make digital or hard copies of part or all of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for third-party components of this work must be honored. For all other uses, contact the Owner/Author.

    Sponsors

    Publisher

    Association for Computing Machinery

    New York, NY, United States

    Publication History

    Published: 14 August 2021

    Check for updates

    Author Tags

    1. artificial intelligence
    2. deep learning
    3. drug discovery
    4. graph representation learning
    5. machine learning
    6. network medicine

    Qualifiers

    • Abstract

    Funding Sources

    • Mila-Samsung Research Contract
    • NSERC
    • CIFAR AI Research Chair

    Conference

    KDD '21
    Sponsor:

    Acceptance Rates

    Overall Acceptance Rate 1,133 of 8,635 submissions, 13%

    Upcoming Conference

    KDD '25

    Contributors

    Other Metrics

    Bibliometrics & Citations

    Bibliometrics

    Article Metrics

    • Downloads (Last 12 months)64
    • Downloads (Last 6 weeks)6
    Reflects downloads up to 09 Jan 2025

    Other Metrics

    Citations

    Cited By

    View all

    View Options

    Login options

    View options

    PDF

    View or Download as a PDF file.

    PDF

    eReader

    View online with eReader.

    eReader

    Media

    Figures

    Other

    Tables

    Share

    Share

    Share this Publication link

    Share on social media